See the DrugPatentWatch profile for Hemiclor
What is “Hemiclor 12.5 mg” used for?
“Hemiclor 12.5 mg” is a brand name for a medicine that contains 12.5 mg of chlorthalidone (a thiazide-type diuretic). It is commonly used to treat high blood pressure (hypertension) and sometimes fluid retention (edema) in certain conditions. [1]
What does “12.5 mg” mean and how is it usually taken?
“12.5 mg” is the strength of the tablet (chlorthalidone 12.5 mg). Typical use is once daily, usually in the morning, but the exact dosing schedule should follow the prescription on your label or your clinician’s instructions. [1]
Common side effects people ask about
With chlorthalidone, people commonly report effects related to fluid and electrolyte changes, such as increased urination, dizziness, or weakness. It can also lower potassium or sodium levels and may raise uric acid or glucose in some patients. Side effects and seriousness vary by dose and individual health status. [1]
Who should be careful before taking it?
Caution is important if you have kidney disease, gout/higher uric acid, electrolyte imbalance (low potassium or sodium), diabetes, or you take other medicines that affect electrolytes. Also, discuss with a clinician if you are pregnant or breastfeeding. [1]
Can it interact with other medicines?
Yes. Diuretics like chlorthalidone can interact with medicines for blood pressure and heart conditions, lithium, diabetes medicines, and drugs that affect potassium. Always check your current medication list with a pharmacist or prescriber before starting. [1]
How quickly does it work?
For blood pressure, some effect can appear within days, but the full benefit can take several weeks of consistent use. For fluid-related swelling, increased urination and symptom relief may start sooner after taking the tablet. [1]
If the dose is missed or stopped
If you miss a dose, take it when you remember unless it’s close to the time of the next dose; don’t double up. Stopping suddenly can worsen blood pressure control. Follow your prescriber’s guidance. [1]
Sources
- https://www.medicines.org.uk/emc/product/2796/smpc